(Circulation. 1997;95:1111-1114.)
© 1997 American Heart Association, Inc.
Articles |
Role of Myocyte Nitric Oxide in ß-Adrenergic Hyporesponsiveness in Heart Failure
the Research Institute of Angiocardiology and Cardiovascular Clinic, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Correspondence to Hiroyuki Tsutsui, MD, PhD, Research Institute of Angiocardiology and Cardiovascular Clinic, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-82, Japan.
Background The positive inotropic response to ß-adrenergic stimulation is attenuated at the isolated myocyte level in heart failure. Nitric oxide (NO) has a negative inotropic effect and attenuates the response to isoproterenol. It has been suggested that NO synthesis is increased in failing myocytes. However, the pathophysiological consequences after induction of NO in myocyte contractility are less clear in the setting of heart failure.
Methods and Results We examined the effects of an NO synthase (NOS) inhibitor on contractile function in myocytes isolated from 11 dogs with rapid pacing–induced heart failure (ejection fraction, 29±2%) and 8 control dogs (ejection fraction, 74±3%). Sarcomere shortening velocity was measured as an index of contractility under four experimental conditions: at baseline, after adding isoproterenol (ISO; 1 nmol/L), after an NOS inhibitor (N
-nitro-L-arginine methyl ester [L-NAME], 0.1 nmol/L), and after L-NAME plus ISO. L-NAME alone had no effects on basal sarcomere shortening velocity in either control or heart failure myocytes. However, L-NAME significantly augmented the inotropic response to isoproterenol in heart failure myocytes (107.1±7.3% [ISO alone] versus 140.6±10.7% [ISO plus L-NAME] increase from baseline; P<.05) but not in control myocytes (135.5±9.9% [ISO alone] versus 137.1±11.4% [ISO plus L-NAME]; P=NS). Myocardial NOS activity measured by the conversion of arginine to citrulline was significantly increased in dogs with heart failure compared with that in control dogs.
Conclusions The increased NO induction in failing myocytes does not alter baseline sarcomere mechanics but attenuates the positive inotropic response to isoproterenol. Thus, myocyte NO plays an important role in the autocrine regulation of the contractile function of myocytes in congestive heart failure.
Key Words: heart failure • endothelium-derived factors • cells • contractility • receptors, adrenergic, beta
This article has been cited by other articles:
 |
|
 |
|
  B. Olshansky, H. N. Sabbah, P. J. Hauptman, and W. S. Colucci Parasympathetic Nervous System and Heart Failure: Pathophysiology and Potential Implications for Therapy Circulation, August 19, 2008; 118(8): 863 - 871. [Full Text] [PDF]
|
|
|
|
 |
|
 V. Dzavik, G. Cotter, H. R. Reynolds, J. H. Alexander, K. Ramanathan, A. L. Stebbins, D. Hathaway, M. E. Farkouh, E. M. Ohman, D. A. Baran, et al. Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study Eur. Heart J., May 1, 2007; 28(9): 1109 - 1116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wenzel, C. Rohde, S. Wingerning, J. Roth, G. Kojda, and K.-D. Schluter Lack of Endothelial Nitric Oxide Synthase-Derived Nitric Oxide Formation Favors Hypertrophy in Adult Ventricular Cardiomyocytes Hypertension, January 1, 2007; 49(1): 193 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ohta, N. Hasebe, S. Tsuji, K. Izawa, Y.-T. Jin, S. Kido, S. Natori, M. Sato, and K. Kikuchi Unequal effects of renin-angiotensin system inhibitors in acute cardiac dysfunction induced by isoproterenol Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2914 - H2921. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.B. Massion, O. Feron, C. Dessy, and J.-L. Balligand Nitric Oxide and Cardiac Function: Ten Years After, and Continuing Circ. Res., September 5, 2003; 93(5): 388 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. McNamara, R. Holubkov, L. Postava, R. Ramani, K. Janosko, M. Mathier, G. A. MacGowan, S. Murali, A. M. Feldman, and B. London Effect of the Asp298 Variant of Endothelial Nitric Oxide Synthase on Survival for Patients With Congestive Heart Failure Circulation, April 1, 2003; 107(12): 1598 - 1602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Funakoshi, T. Kubota, N. Kawamura, Y. Machida, A. M. Feldman, H. Tsutsui, H. Shimokawa, and A. Takeshita Disruption of Inducible Nitric Oxide Synthase Improves {beta}-Adrenergic Inotropic Responsiveness but Not the Survival of Mice With Cytokine-Induced Cardiomyopathy Circ. Res., May 17, 2002; 90(9): 959 - 965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-J. Kim, Y.-K. Kim, G. Takagi, C.-H. Huang, Y.-J. Geng, and S. F. Vatner Enhanced iNOS function in myocytes one day after brief ischemic episode Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H423 - H428. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Gealekman, Z. Abassi, I. Rubinstein, J. Winaver, and O. Binah Role of Myocardial Inducible Nitric Oxide Synthase in Contractile Dysfunction and {beta}-Adrenergic Hyporesponsiveness in Rats With Experimental Volume-Overload Heart Failure Circulation, January 15, 2002; 105(2): 236 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Nikolaidis, T. Hentosz, A. Doverspike, R. Huerbin, C. Stolarski, Y.-T. Shen, and R. P. Shannon Mechanisms whereby rapid RV pacing causes LV dysfunction: perfusion-contraction matching and NO Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2270 - H2281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. E. Hill The Inflammatory Response to Cardiopulmonary Bypass-- Should It Be Treated? Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 229 - 235. [Abstract] [PDF]
|
|
|
|
|
|
C. Y. T. Hart, E. L. Hahn, D. M. Meyer, J. C. Burnett Jr., and M. M. Redfield Differential effects of natriuretic peptides and NO on LV function in heart failure and normal dogs Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H146 - H154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ukai, C.-P. Cheng, H. Tachibana, A. Igawa, Z.-S. Zhang, H.-J. Cheng, and W. C. Little Allopurinol Enhances the Contractile Response to Dobutamine and Exercise in Dogs With Pacing-Induced Heart Failure Circulation, February 6, 2001; 103(5): 750 - 755. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Abe, M. Tokumura, T. Ito, T. Murai, A. Takashima, and N. Ibii Involvement of iNOS in postischemic heart dysfunction of stroke-prone spontaneously hypertensive rats Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H668 - H673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Arimura, K. Egashira, R. Nakamura, T. Ide, H. Tsutsui, H. Shimokawa, and A. Takeshita Increased inactivation of nitric oxide is involved in coronary endothelial dysfunction in heart failure Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H68 - H75. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Tsutsui, T. Ide, S. Hayashidani, N. Suematsu, H. Utsumi, R. Nakamura, K. Egashira, and A. Takeshita Greater susceptibility of failing cardiac myocytes to oxygen free radical-mediated injury Cardiovasc Res, January 1, 2001; 49(1): 103 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. C. Prahash, S. Gupta, and I. S. Anand Myocyte Response to {beta}-Adrenergic Stimulation Is Preserved in the Noninfarcted Myocardium of Globally Dysfunctional Rat Hearts After Myocardial Infarction Circulation, October 10, 2000; 102(15): 1840 - 1846. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kinugawa, H. Tsutsui, S. Hayashidani, T. Ide, N. Suematsu, S. Satoh, H. Utsumi, and A. Takeshita Treatment With Dimethylthiourea Prevents Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction in Mice : Role of Oxidative Stress Circ. Res., September 1, 2000; 87(5): 392 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Prabhu, B. Chandrasekar, D. R. Murray, and G. L. Freeman {beta}-Adrenergic Blockade in Developing Heart Failure : Effects on Myocardial Inflammatory Cytokines, Nitric Oxide, and Remodeling Circulation, May 2, 2000; 101(17): 2103 - 2109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ide, H. Tsutsui, S. Kinugawa, N. Suematsu, S. Hayashidani, K. Ichikawa, H. Utsumi, Y. Machida, K. Egashira, and A. Takeshita Direct Evidence for Increased Hydroxyl Radicals Originating From Superoxide in the Failing Myocardium Circ. Res., February 4, 2000; 86(2): 152 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. FUJIMURA, S. SUMITA, E. NARIMATSU, Y. NAKAYAMA, Y. SHITINOHE, and A. NAMIKI Effects of Isoproterenol on Diaphragmatic Contractility in Septic Peritonitis Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 440 - 446. [Abstract] [Full Text]
|
|
|
|
|
|
S. Kinugawa, H. Tsutsui, S. Satoh, M. Takahashi, T. Ide, K. Igarashi-Saito, K.-i. Arimura, K. Egashira, and A. Takeshita Role of Ca2+ availability to myofilaments and their sensitivity to Ca2+ in myocyte contractile dysfunction in heart failure Cardiovasc Res, November 1, 1999; 44(2): 398 - 406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. De Wolf, L. Foubert, Y. Van Belleghem, K. Mareels, D. Matthys, H. Verhaaren, and G. Van Nooten The influence of low afterload on the nature of the stress-velocity relationship J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1219 - 1225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ide, H. Tsutsui, S. Kinugawa, H. Utsumi, D. Kang, N. Hattori, K. Uchida, K.-i. Arimura, K. Egashira, and A. Takeshita Mitochondrial Electron Transport Complex I Is a Potential Source of Oxygen Free Radicals in the Failing Myocardium Circ. Res., August 20, 1999; 85(4): 357 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-L. Balligand Regulation of cardiac {beta}-adrenergic response by nitric oxide Cardiovasc Res, August 15, 1999; 43(3): 607 - 620. [Full Text] [PDF]
|
|
|
|
|
|
S. Kinugawa, H. Tsutsui, T. Ide, R. Nakamura, K.-i. Arimura, K. Egashira, and A. Takeshita Positive inotropic effect of insulin-like growth factor-1 on normal and failing cardiac myocytes Cardiovasc Res, July 1, 1999; 43(1): 157 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Heymes, M. Vanderheyden, J. G. F. Bronzwaer, A. M. Shah, and W. J. Paulus Endomyocardial Nitric Oxide Synthase and Left Ventricular Preload Reserve in Dilated Cardiomyopathy Circulation, June 15, 1999; 99(23): 3009 - 3016. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. W Moe and P. Armstrong Pacing-induced heart failure: a model to study the mechanism of disease progression and novel therapy in heart failure Cardiovasc Res, June 1, 1999; 42(3): 591 - 599. [Full Text] [PDF]
|
|
|
|
|
|
S. E. Harding, C. H. Davies, A. M. Money-Kyrle, and P. A. Poole-Wilson An inhibitor of nitric oxide synthase does not increase contraction or {beta}-adrenoceptor sensitivity of ventricular myocytes from failing human heart Cardiovasc Res, December 1, 1998; 40(3): 523 - 529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Stein, T. Eschenhagen, J. Rudiger, H. Scholz, U. Forstermann, and I. Gath Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1179 - 1186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bartunek, S. Dempsey, E. O. Weinberg, N. Ito, M. Tajima, S. Rohrbach, and B. H. Lorell Chronic L-arginine treatment increases cardiac cyclic guanosine 5'-monophosphate in rats with aortic stenosis: effects on left ventricular mass and beta-adrenergic contractile reserve J. Am. Coll. Cardiol., August 1, 1998; 32(2): 528 - 535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fukuchi, S. N. A. Hussain, and A. Giaid Heterogeneous Expression and Activity of Endothelial and Inducible Nitric Oxide Synthases in End-Stage Human Heart Failure : Their Relation to Lesion Site and ß-Adrenergic Receptor Therapy Circulation, July 14, 1998; 98(2): 132 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Igarashi-Saito, H. Tsutsui, S. Yamamoto, M. Takahashi, S. Kinugawa, H. Tagawa, M. Usui, M. Yamamoto, K. Egashira, and A. Takeshita Role of SR Ca2+-ATPase in contractile dysfunction of myocytes in tachycardia-induced heart failure Am J Physiol Heart Circ Physiol, July 1, 1998; 275(1): H31 - H40. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ferrari Tumor necrosis factor in CHF: a double facet cytokine Cardiovasc Res, March 1, 1998; 37(3): 554 - 559. [Full Text] [PDF]
|
|
|
|
|
|
J. M. Hare, M. M. Givertz, M. A. Creager, and W. S. Colucci Increased Sensitivity to Nitric Oxide Synthase Inhibition in Patients With Heart Failure : Potentiation of ß-Adrenergic Inotropic Responsiveness Circulation, January 20, 1998; 97(2): 161 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Paulus, S. Kastner, P. Pujadas, A. M. Shah, H. Drexler, and M. Vanderheyden Left Ventricular Contractile Effects of Inducible Nitric Oxide Synthase in the Human Allograft Circulation, November 18, 1997; 96(10): 3436 - 3442. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Ishibashi, Y. Urabe, H. Tsutsui, S. Kinugawa, M. Sugimachi, M. Takahashi, S. Yamamoto, H. Tagawa, K. Sunagawa, and A. Takeshita Negative Inotropic Effect of Basic Fibroblast Growth Factor on Adult Rat Cardiac Myocyte Circulation, October 21, 1997; 96(8): 2501 - 2504. [Abstract] [Full Text]
|
|
|
|
|
|
H. Funakoshi, T. Kubota, Y. Machida, N. Kawamura, A. M. Feldman, H. Tsutsui, H. Shimokawa, and A. Takeshita Involvement of inducible nitric oxide synthase in cardiac dysfunction with tumor necrosis factor-alpha Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2159 - H2166. [Abstract] [Full Text] [PDF]
|
|